Picture of Bakhu Holdings logo

BKUH Bakhu Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapValue Trap

Momentum

Relative Strength (%)
1m+2.83%
3m+142.61%
6m-79.14%
1yr-80.37%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202431st Jul 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Bakhu Holdings EPS forecast chart

Profile Summary

Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.

Directors

Last Annual
July 31st, 2023
Last Interim
January 31st, 2024
Incorporated
April 24th, 2008
Public Since
June 22nd, 2009
No. of Shareholders
387
No. of Employees
2
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
301,302,983

BKUH Share Price Performance

Upcoming Events for BKUH

Q3 2024 Bakhu Holdings Corp Earnings Release

Similar to BKUH

Picture of 4Cable TV International logo

4Cable TV International

us flag iconPink Sheets on Nasdaq

Picture of Abattis Bioceuticals logo

Abattis Bioceuticals

us flag iconPink Sheets on Nasdaq

Picture of Accelera Innovations logo

Accelera Innovations

us flag iconPink Sheets on Nasdaq

Picture of ACI Global logo

ACI Global

us flag iconPink Sheets on Nasdaq

Picture of Quantum Medical Transport logo

Quantum Medical Transport

us flag iconPink Sheets on Nasdaq

FAQ